References
- Csanyi E, Halisz M. Cross-resistance studies on 1, 6 dibromodideoxy-D-mannitol (DBM)-resistant Yosida sc sarcoma. Br J Cancer 1967; 21: 353–357
- Institoris L, Nemeth L, Somfai S, et al. Investigation into the correlation of cystostatic activity with the in vitro diepoxide formation on some terminally substituted hexitols. Neoplasma 1974; 17: 15–24
- Nemeth L, Institoris L, Somfai S, et al. Pharmacologic and antitumor effects of 1,2:5,6 dianhydrogalactitol (NSC-132313). Cancer Chemother Rep 1972; 56: 593–602
- Levin V A, Freeman-Dove M A, Maroten C E. Dianhydrogalactitol (NSC-132313): pharmacokinetics in normal and tumor-bearing rat brain and antitumor activity against three intracerebral rodent tumors. J Natl Cancer Inst 1976; 56: 535–539
- Helson L, Rozsa P, Hajdu E, et al. Dianhydrogalactitol and neural tumors: An in vitro, in vivo preclinical evaluation. Cancer Treat Rep 1980; 64: 1287–1294
- Palyi I. Survival and phase sensitivity of HeLa cells treated with dianhydrogalactitol (NSC-132313). Cancer Chemother Rep 1975; 59: 493–499
- Biedler J., Helson L, Spengler B A. Morphology and growth, tumorigenicity and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 1973; 33: 2643–2652
- Helson L, Helson C, Rubenstein R, (1977) Human neuroblastoma in nude mice. Proceedings of the Second International Workshop on Nude Mice. 1977, T Nomura, et al. University of Tokyo Press, Tokyo, 291–303
- Darzynkiewicz Z., Traganos F, Sharpless T, et al. Conformation of RNA in vitro, as studied by acridine orange staining and automated cytofluorometry. Exptl Cell Res 1975; 95: 143–153
- Traganos F, Darzynkiewicz Z, Sharpless T., et al. Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in flow cytofluorometric system. J Histochem Cytochem 1977; 25: 46
- Coulson P B, Bishop A O, Lenarduzzi R. Quantitation of cellular deoxyribonucleic acid by flow microfluorometry. J Histochem Cytochem 1977; 25: 1147–1153
- Bauer K D., Dethlefsen L A. Total cellular RNA content. Correlation between flow cytometry and ultraviolet spectroscopy. J Histochem Cytochem 1980; 28: 493
- Andreeff M, Darzynkiewicz Z, Sharpless T K, et al. Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood 1980; 55: 282
- Kapuscinski, Darzynkiewicz Z, Melamed M R. Luminescence of the solid complexes of acridine orange with RNA. Cytometry, in press
- Sharpless T K. Cytometric Data Processing. Flow Cytometry and Sorting, M R Melamed, P F. Mullaney, M L Mendelsohn. John Wiley and Sons, New York 1979; 359
- Eagan R T, Childs D S, Jr., Layton D D, Jr., et al. Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma. JAMA 1979; 241: 2046–2050
- Espana P., Wiemik P H, Walker M D. Phase II study of dianhydrogalactitol in malignant glioma. Cancer Treat Rep 1978; 62: 1199–1200
- Eagan R T, Creagan E T, Bisel H F., et al. Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumors. Oncology 1981; 38: 4–6
- Barranco S C, Flournoy D R. Cell killing, kinetics and recovery responses induced by 1,2:5,6-dianhydrogalactitol in dividing and non-dividing cell in vitro. J Natl Cancer Inst 1977; 58: 657–663
- Barranco S C, Personal communication
- Nomura K, Hoshino T, Deen D F, et al. Perturbed cell kinetics of 91. rat brain tumor cells following dianhydrogalactitol. Cancer Treat Rep 1978; 62: 2055–2061